Get started

Marijuana

WEED perfect fib boucesWow volatility is CRAZY!! making fib bounces within days. Not wasting any time hitting targets! Target for WEED reached at 30$ retracing to 62% fib. Now hopefully a short back down for the final correction wave from the ABC pattern First target pickup is at 21 again, second is at 16$. Good luck and remember to take partial profits in case in keeps running upwards, WEED could very well keep going to 35$ but don't fomo, patience is key, it will come back down again before legalization.
TSX:WEEDShort
by MysteriousPersian
22
$BYOC Continues trending Sideways on Fib Lines Awaiting Updates$BYOC Continues on a sideways trajectory with continued immense accumulation as it did in the .02 area before the push to .15 $BYOC has maintained legs very well on its way up and I anticipate a break to the upside here this week. The next update is said to be another acquisition of a major entity that will bring in another round of considerable revenue for the company on a yearly basis. There are now anticipated to be 3 more acquisitions from the latest word on the grapevine and it can be seen by the accumulation by insiders that this is set to be a record breaking year for the company. A list of additional DD can be found in the posted links below.
OTC:BYOCLong
by StockGuild
ProjeXions Series - Vol1 - Cannabis Industry - CBIS, 2-YEAR, OTCThis is a work-flow experiment. The details surrounding the indicators and metrics used to arrive at my conclusions will be discussed when my targets are met. Cannabis Science, Inc. takes advantage of its unique understanding of metabolic processes to provide novel treatment approaches to a number of illnesses for which current treatments and understanding remain unsatisfactory. Cannabinoids have an extensive history dating back thousands of years, and currently, there are a growing number of peer-reviewed scientific publications that document the underlying biochemical pathways that cannabinoids modulate. The Company works with leading experts in drug development, medicinal characterization, and clinical research to develop, produce, and commercialize novel therapeutic approaches for the treatment for illnesses caused by infections as well as for age-related illness. Our initial focus is on cancers, HIV/AIDS, and neurological conditions. The Company is proceeding with the research and development of its proprietary drugs as a part of this initial focus: CS-S/BCC-1, CS-TATI-1, and CS-NEURO-1, respectively.
C
by ZpaceBuddha
ProjeXions Series - Vol1 - Cannabis Industry - NDEV, 3-YEAR, OTCThis is a work-flow experiment. The details surrounding the indicators and metrics used to arrive at my conclusions will be discussed if & when my targets are met. Some data factors used: trend lines, E.Waves, channels, fibs, MA, RSI etc. Novus Acquisition & Development Corp. (NDEV), through its subsidiary WCIG Insurance, provides health insurance and related insurance solutions within the wellness and medical marijuana industries in states where legal programs exist. Novus has developed its infrastructure within many lines of the insurance business such as, health, property & casualty, life, accident and fixed annuities. Novus medical cannabis benefits package will work as outside developers and will not cultivate, handle, transport grow, extract, dispense, put up for sale, put on the market, vend, deliver, supply, circulate, or trade cannabis or any substances that violate the United States law or the Controlled Substances Act, nor does it intend to do so in the future and will continue to follow state and federal laws. The statements made about specific products have not been evaluated by the United States Food and Drug Administration (FDA) and are not intended to diagnose, treat, cure or prevent disease. All information provided on these press releases or any information contained on or in any product label or packaging is for informational purposes only and is not intended as a substitute for advice from your physician or other health care professional. Once a push notification is competed the transaction is solely between the state-licensed dispensary and the registered patient. The state laws are in conflict with the federal Controlled Substances Act. The current administration has effectively stated that it is not an efficient use of resources to direct federal law enforcement agencies to prosecute those lawfully abiding by state designated laws, allowing the use and distribution of medical marijuana. However, there is no guarantee that the current administration, nor any future administration, will not change this policy and decide to enforce the federal laws strongly. Any such change in the federal government's enforcement of current federal laws could cause significant financial changes to Novus Medical Group. While we do not intend to harvest, distribute or sell cannabis or cannabis related products, we may be harmed by a change in enforcement by federal or state governments.
OTC:NDEV
by ZpaceBuddha
$GBLX - GB Sciences Marijuana Play$GBLX - GB Sciences is a great way to get exposure to the Marijuana industry that of course we all know is booming. The attraction here for me was a deal GB Sciences made late last year with LSU to provide medical Marijuana (THC) to approved patients in Louisiana as well as other retail revenue streams they have in other states. Although they are an OTC stock the deal with LSU legitimized them as a viable company in my eyes. The stock has recently had a great run and I took profits from my buys in the low to mid $0.20 range after observing a reversal on the stock. If you notice in the chart it has now broken through the lower end up the uptrend channel that had developed prior to its huge run to $1.56 along with several key Fibonacci Retracement levels. Considering it blew right through the 61.8% and 50.0% retracement levels I am expecting a dip down possibly to test the 38.2%. If 38.2% can't hold then they next key level of support would be $0.64 which held well in mid December followed by Fib Retracement 23.6% at a price of $0.547. I plan to add 25-50% of my position back at Buy Target 1 depending on how strong or weak it looks. I will initially set a buy limit order for 25% at target 1 to get an auto fill and will observe manually to see if it bounces off of this level. Buy Target 1: $0.74 Buy Target 2: $0.64 Buy Target 3: $0.547 Sell Target 1: $1.56 (25-50% of Position) Sell Target 2: $2.37 Sell Target 3: $3.70 (Longer Term)
OTC:GBLXLong
by TheBossTrader
$LVGI Continues to be Accumulated ahead of News$LVGI Began the day being tapped at .0005 ask shares being eaten up by people who continue to accumulate a % of the company ahead of anticipated updates for its Marijuana business expansion. The latest PR by them on November 17th indicated a Joint partnership with Ascend Global Systems: www.releasewire.com A tweet by the CEO on Jan 9th shows further updates about the partnership and expansion to come: twitter.com "Three of our HempCore products should be made available to our Ascend Global Services distributors this week. Also working on getting LVGI set-up as Platinum Distributor for additional revenue stream."
OTC:LVGILong
by StockGuild
Breakout Long Idea on $ACBFF - Aurora Cannabis Inc$ACBFF has a good setup for a long idea on a breakout. The stock is extended but with Marijuana being so hot right now the momentum alone can make this a nice trade. This stock is actually the U.S. version of Canada's ACB:CN. What I like for the trade's potential is marijuana is legal in Canada which gives people confidence that these Canadian based stocks can really run with limited headwinds. $ACBFF showed up today on my 'Darvas Breakout Scanner' and I currently have an alert, on my thinkorswim, setup at $11.80 which will likely trigger tomorrow. Entry: Above $11.83 Stop: $10.85 Target 1: $15.79 Risk:Reward 3.99 Target 2: $16.80 Risk:Reward 5.01
ALong
by TheBossTrader
2
$LVGI Advances on MJ and Amazon Products + Updates$LVGI a Trip pennystock currently has been active as of lately with its Hempcore line of products selling on Amazon with substantial revenues. Other brands associated with $LVGI are: Limitless Body Limitless Health Slam Infusionation The company is planning major expansion in 2018 and I expect the PPS to expand along with it as well. Currently sitting at .0004 I expect it will be trading around .0050 by Summer time. The Company also has plans to be current with OTCMarkets and uplist to higher exchanges.
OTC:LVGILong
by StockGuild
(KSHB) Kush Bottles Perfect Stock, CANSLIM, Weed StockThis is a GO BIG AND HOLD stock. I don't see perfect stocks on the OTC markets very often. In fact, I suspect the only reason this stock isn't on the Nasdaq is because it is a weed stock. They don't sell marijuana though, but they probably have plans of entering this sector eventually. They just sell pipes and marijuana paraphernalia, located in California, the 8th largest economy in the world. They are also almost 10 years old now. This stock is a no brainer really. Perfect. The float is perfect; the earnings growth is perfect; the industry is perfect; the buzz is perfect; the volume, perfect; the breakout, again, perfect; the name, perfect; the cup and handle, perfect. Everything about this stock is perfect. Entry is 3/4th's tomorrow, January 12th, 2017, add the rest on a pull back or on next big volume day. This stock is going to $20 eventually. A perfect long term hold
KLong
by alipipefitter
8
LG.v Technicals Looking GoodLG has some good looking technicals at the moment. Falling wedge forming nice. Also could be a pennant with the older trendlines. Flirting with the 100MA and this has shown great support for a swing trade in the past. Stochastic is pretty low, but could stay down. RSI is not quite oversold but showing resistance to going down any further. Money flow has stayed somewhat strong. MACD is curling up at the moment. Key levels at .59 and .92. These will act as support and resistance. I will be taking a position from .66 and building my position all the way down to .60 if the wedge breakout does not occur. Planning to sell around the .87-.89 level. Also opportunity for a breakout play down the road if we are see great trend support as it nears the .92 level.
TSXV:LGLong
by koples
2
CANN Cannabis Coin Low coin count. Undervalued. Load up!Flag pennant closing, 50 day moving average right below us, and RSI moving into the buy zone. All signs point to a pop in my opinion. With a very low coin count this could move again crazy fast. Only 91,859,176 coins!!!! That's more than half of Hempcoin THC and a quarter Potcoin POT which are trading at much higher levels. Get them now because they are going to be hard to come by soon. Buy Zone 1500-1800. Target 1: 0.00002280 Target 2: 0.00002986 Target 3: 0.00004710
CLong
by CanaanIsLegend
7